Publication:
Leptin Levels in Henoch-Schönlein Purpura

dc.authorscopusid6506633542
dc.authorscopusid7003365098
dc.authorscopusid56986275600
dc.authorscopusid7003707808
dc.authorscopusid6603086789
dc.contributor.authorAliyazicioǧlu, Y.
dc.contributor.authorÖzkaya, O.
dc.contributor.authorYakut, H.
dc.contributor.authorİşlek, I.
dc.contributor.authorAlvur, M.
dc.date.accessioned2020-06-21T15:23:51Z
dc.date.available2020-06-21T15:23:51Z
dc.date.issued2007
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Aliyazicioǧlu] Yüksel, Department of Biochemistry, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Özkaya] Ozan, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yakut] Husamettin, Department of Pediatrics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [İşlek] İsmail, Department of Pediatrics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Alvur] Muhlise, Department of Biochemistry, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractThe objective of this paper is to assess the possible role of nitric oxide (NO) and leptin in Henoch-Schönlein purpura (HSP). We investigated the serum leptin and total nitrite levels in 22 children with HSP in the acute phase and after remission and in 20 age- and sex-matched healthy control. Serum leptin levels (nanograms per milliliter; median, min-max) were statistically higher in the acute phase (12.9, 9.1-19.5) than those in the remission phase (6.1, 3.7-10.5, p<0.001) and in the control group (4.9, 3.8-7.5, p<0.001). Also, serum nitrite levels (micromole per liter; median, min-max) were higher in children in the acute phase (45.0, 32.0-60.0) compared to those in remission phase (30.5, 23.0-48.0) and in the control group (29.5, 18.0-38.0) (p<0.001, p<0.001, respectively). There was a positive correlation between serum leptin and total nitrite levels (r=0.65, p<0.001). We have demonstrated that serum leptin and NO levels were increased during the acute phase in children with HSP, and returned to normal levels in remission. We suggest that leptin and NO may have a role in the immunoinflammatory process of HSP, especially in the acute phase. Further studies are needed to clearly establish the roles of leptin and NO in the pathogenesis of HSP. © Clinical Rheumatology 2006.en_US
dc.identifier.doi10.1007/s10067-006-0363-6
dc.identifier.endpage375en_US
dc.identifier.issn0770-3198
dc.identifier.issn1434-9949
dc.identifier.issue3en_US
dc.identifier.pmid16816886
dc.identifier.scopus2-s2.0-33947691257
dc.identifier.scopusqualityQ1
dc.identifier.startpage371en_US
dc.identifier.urihttps://doi.org/10.1007/s10067-006-0363-6
dc.identifier.volume26en_US
dc.identifier.wosWOS:000243969700016
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherSpringer London Ltden_US
dc.relation.ispartofClinical Rheumatologyen_US
dc.relation.journalClinical Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHenoch-Schönlein Purpuraen_US
dc.subjectLeptinen_US
dc.subjectNitric Oxideen_US
dc.titleLeptin Levels in Henoch-Schönlein Purpuraen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files